Overall, these findings highlight the differential immune checkpoint expression profiles between primary and brain metastatic breast cancer cells, with significant upregulation of PD-L1 and other key immune checkpoints in 231Br cells, which may play a crucial role in their enhanced metastatic potential and immune evasion capabilities. This evidence concerns the gene CD274 and breast cancer.